215 related articles for article (PubMed ID: 34245663)
1. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise.
Amiri A; Chovanec M; Oliva V; Sedliak M; Mego M; Ukropec J; Ukropcová B
Andrology; 2021 Nov; 9(6):1879-1892. PubMed ID: 34245663
[TBL] [Abstract][Full Text] [Related]
2. Impact of a one-year supervised physical activity program on long-term cancer-related fatigue and mediating effects of the gut microbiota in metastatic testicular cancer patients: protocol of the prospective multicentre, randomized controlled phase-III STARTER trial.
Noh H; Anota A; Mongondry R; Meyrand R; Dupuis C; Schiffler C; Marijnen P; Rinaldi S; Lachuer J; Keski-Rahkonen P; Gunter MJ; Fléchon A; Fervers B; Pérol O
BMC Cancer; 2024 Jan; 24(1):84. PubMed ID: 38225551
[TBL] [Abstract][Full Text] [Related]
3. Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.
Kerns SL; Fung C; Monahan PO; Ardeshir-Rouhani-Fard S; Abu Zaid MI; Williams AM; Stump TE; Sesso HD; Feldman DR; Hamilton RJ; Vaughn DJ; Beard C; Huddart RA; Kim J; Kollmannsberger C; Sahasrabudhe DM; Cook R; Fossa SD; Einhorn LH; Travis LB;
J Clin Oncol; 2018 May; 36(15):1505-1512. PubMed ID: 29617189
[TBL] [Abstract][Full Text] [Related]
4. Long-term toxicity of cisplatin in germ-cell tumor survivors.
Chovanec M; Abu Zaid M; Hanna N; El-Kouri N; Einhorn LH; Albany C
Ann Oncol; 2017 Nov; 28(11):2670-2679. PubMed ID: 29045502
[TBL] [Abstract][Full Text] [Related]
5. High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy.
Hapakova N; Sestakova Z; Holickova A; Hurbanova L; Miskovska V; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Obertova J; Palacka P; Sycova-Mila Z; Mardiak J; Chovanec M; Mego M
Clin Genitourin Cancer; 2019 Oct; 17(5):e1020-e1025. PubMed ID: 31281064
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-Induced Peripheral Neuropathy (CIPN) as a Predictor of Decreased Quality of Life in Testicular Germ Cell Tumor Survivors.
Orszaghova Z; Galikova D; Lesko P; Obertova J; Rejlekova K; Sycova-Mila Z; Palacka P; Kalavska K; Svetlovska D; Mladosievicova B; Mardiak J; Mego M; Chovanec M
Clin Genitourin Cancer; 2024 Jun; 22(3):102067. PubMed ID: 38555680
[TBL] [Abstract][Full Text] [Related]
7. Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.
Suarez-Ibarrola R; Abufaraj M; Shariat SF
Curr Opin Urol; 2018 Sep; 28(5):485-490. PubMed ID: 30044319
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
Schmidtova S; Kalavska K; Kucerova L
Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
[TBL] [Abstract][Full Text] [Related]
9. Testicular cancer survivorship: research strategies and recommendations.
Travis LB; Beard C; Allan JM; Dahl AA; Feldman DR; Oldenburg J; Daugaard G; Kelly JL; Dolan ME; Hannigan R; Constine LS; Oeffinger KC; Okunieff P; Armstrong G; Wiljer D; Miller RC; Gietema JA; van Leeuwen FE; Williams JP; Nichols CR; Einhorn LH; Fossa SD
J Natl Cancer Inst; 2010 Aug; 102(15):1114-30. PubMed ID: 20585105
[TBL] [Abstract][Full Text] [Related]
10. Gonadal function in men with testicular germ cell cancer: the influence of cisplatin-based chemotherapy.
Hansen PV; Hansen SW
Eur Urol; 1993; 23(1):153-6. PubMed ID: 8386643
[TBL] [Abstract][Full Text] [Related]
11. Habitual physical activity modulates cardiometabolic health in long-term testicular cancer survivors.
Amiri A; Krumpolec P; Mego M; Ukropcová B; Chovanec M; Ukropec J
Support Care Cancer; 2023 Aug; 31(9):539. PubMed ID: 37632597
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
[TBL] [Abstract][Full Text] [Related]
13. Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship.
Christensen JF; Bandak M; Campbell A; Jones LW; Højman P
Acta Oncol; 2015 May; 54(5):592-9. PubMed ID: 25751759
[TBL] [Abstract][Full Text] [Related]
14. Impact of pain and adverse health outcomes on long-term US testicular cancer survivors.
Dinh PC; Monahan PO; Fosså SD; Sesso HD; Feldman DR; Dolan ME; Nevel K; Kincaid J; Vaughn DJ; Martin NE; Sanchez VA; Einhorn LH; Frisina R; Fung C; Kroenke K; Travis LB
J Natl Cancer Inst; 2024 Mar; 116(3):455-467. PubMed ID: 37966940
[TBL] [Abstract][Full Text] [Related]
15. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
16. Fertility after chemotherapy for testicular cancer.
Taksey J; Bissada NK; Chaudhary UB
Arch Androl; 2003; 49(5):389-95. PubMed ID: 12893517
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin related cardiotoxicity - acute and chronic cardiovascular morbidity in a testicular cancer survivor.
Morrow AJ; Cameron AC; Payne AR; White J; Lang NN
Scott Med J; 2020 Feb; 65(1):24-27. PubMed ID: 31886736
[No Abstract] [Full Text] [Related]
18. Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis.
Li H; Zhu C; Wu J; Ma Y; Jin X; Wei X; Wang K; Li H
Int Urol Nephrol; 2021 Mar; 53(3):471-477. PubMed ID: 33052518
[TBL] [Abstract][Full Text] [Related]
19. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD
J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318
[TBL] [Abstract][Full Text] [Related]
20. Physical long-term side-effects in young adult cancer survivors: germ cell tumors model.
Kourie HR; Klastersky JA
Curr Opin Oncol; 2017 Jul; 29(4):229-234. PubMed ID: 28463858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
